Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. Additionally we are shipping Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Proteins (4) and Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Kits (1) and many more products for this protein.
Showing 10 out of 77 products:
Human Polyclonal RARRES3 Primary Antibody for IHC, WB - ABIN2782646
Lotz, Kellner, Heitmann, Nazarenko, Noske, Malek, Gontarewicz, Schäfer, Sers: Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanisms. in International journal of cancer. Journal international du cancer 2005
Human Polyclonal RARRES3 Primary Antibody for ELISA, WB - ABIN238674
Tsai, Shyu, Jiang: RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. in Cellular signalling 2007
Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma
miR (show MLXIP Antibodies)-34a is an antioncogene in multiple tumors, in this study, RIG-I (show DDX58 Antibodies) and miR (show MLXIP Antibodies)-34a suppressed cell growth, proliferation, migration, and invasion in cervical cancer cells in vitro. miR (show MLXIP Antibodies)-34a was validated as a new regulator of RIG-I (show DDX58 Antibodies) by binding to its 3' untranslated region and upregulating its expression level.
Letter: Interleukin-22 (show IL22 Antibodies) inhibits tazarotene-induced gene 3 expression in keratinocytes via MAPK (show MAPK1 Antibodies)-ERK1/2 (show MAPK1/3 Antibodies) and JAK2 (show JAK2 Antibodies)/STAT3 (show STAT3 Antibodies) signaling.
TRIM25 (show TRIM25 Antibodies) plays an additional role in RIG-I (show DDX58 Antibodies)/MDA5 (show IFIH1 Antibodies) signaling other than RIG-I (show DDX58 Antibodies) ubiquitination via activation of NF-kappaB (show NFKB1 Antibodies).
These observations highlight the importance of RIG-I (show DDX58 Antibodies) signaling in anti-HIV innate immunity in macrophages, which may be beneficial for the treatment of HIV and aid in the understanding of the neuropathogenesis of HAND.
Gal1 (show LGALS1 Antibodies) and gal3 (show LGALS3 Antibodies) regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase (show NEU Antibodies) by modulating the expression of SOCS1 (show SOCS1 Antibodies) and RIG1.
findings provide a new insight into the molecular link between p53 (show TP53 Antibodies), protein acylation and Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling whereby RARRES3 plays a pivotal role in modulating the acylation status of signaling proteins.
During Crimean-Congo hemorrhagic fever virus infection, RIG-I (show DDX58 Antibodies) mediated a type I interferon (show IFNA Antibodies) response via MAVS (show MAVS Antibodies).
the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death.
Viral pseudo-enzymes activate RIG-I (show DDX58 Antibodies) via deamidation to evade cytokine production.
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
retinoic acid receptor responder (tazarotene induced) 3
, retinoic acid receptor responder protein 3
, HRAS-like suppressor 4
, RAR-responsive protein TIG3
, retinoic acid-inducible gene 1
, retinoid-inducible gene 1 protein
, tazarotene-induced gene 3 protein